Emerging pharmacotherapy for obesity

  title={Emerging pharmacotherapy for obesity},
  author={L. Aronne and A. Powell and C. Apovian},
  journal={Expert Opinion on Emerging Drugs},
  pages={587 - 596}
  • L. Aronne, A. Powell, C. Apovian
  • Published 2011
  • Medicine
  • Expert Opinion on Emerging Drugs
  • Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have tripled over the past three decades and are predicted to rise even further. The need for safe and effective therapies is great and has gone unmet. Areas covered: This review will summarize the emerging pharmacological treatments for obesity. The research discussed includes Phase III and early-phase clinical trials as well as recently published data regarding emerging treatment therapies. Expert… CONTINUE READING
    Lorcaserin Hcl for the treatment of obesity
    • 19
    The effect of topiramate on weight loss in patients with type 2 diabetes
    • 12
    • PDF
    Outstanding Scientific Achievement Award Lecture 2011: Defeating Diabesity
    • 34
    • PDF


    Publications referenced by this paper.
    Meta-Analysis: Pharmacologic Treatment of Obesity
    • 746
    • PDF
    Long-term pharmacotherapy for obesity and overweight.
    • 435
    • PDF
    Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    • 15,303
    • PDF
    The obesity epidemic, metabolic syndrome and future prevention strategies
    • 544
    Safety of obesity drugs
    • 58
    Potential of Surgery for Curing Type 2 Diabetes Mellitus
    • 346
    • PDF
    Current estimates of the economic cost of obesity in the United States.
    • 1,266